Activity Monitoring for Parkinson's Disease and Multiple Sclerosis
What You Need to Know Before You Apply
What is the purpose of this trial?
The trial aims to understand how individuals with Parkinson's Disease and Multiple Sclerosis maintain activity over a year. It employs a health app and an activity tracker to monitor daily exercise and physical activity through Remote Therapeutic Monitoring Exercise Tracking. The goal is to assess how these tools can aid in managing these conditions. This trial targets those who can walk with minimal assistance, have Parkinson's or Multiple Sclerosis, and wish to improve their physical activity. Participants need a smartphone and must be willing to use a health app. As an unphased trial, it provides a unique opportunity to contribute to research that could enhance daily life for many.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this remote therapeutic monitoring is safe for people with Parkinson's Disease and Multiple Sclerosis?
Research has shown that using remote tools like exercise tracking apps and devices is safe for people with Parkinson's Disease and Multiple Sclerosis. One study found that telerehabilitation, which uses similar remote monitoring, was safe, easy to use, and effective for people with mild-to-moderate Parkinson's. Thus, tracking activity through an app or device should not cause harm. It helps monitor physical activity and exercise without any serious side effects reported so far.12345
Why are researchers excited about this trial?
Researchers are excited about the remote therapeutic monitoring for Parkinson's Disease and Multiple Sclerosis because it offers a new way to track and manage these conditions using technology. Unlike traditional treatments that rely on medication or in-person therapy, this approach uses a connected health app and a personal activity tracker to monitor physical activity and exercise behaviors remotely. This method empowers patients to engage in their care actively and allows doctors to adjust treatments based on real-time data, potentially leading to more personalized and effective management of symptoms.
What evidence suggests that remote therapeutic monitoring is effective for Parkinson's Disease and Multiple Sclerosis?
Research shows that remote patient monitoring (RPM), which participants in this trial will receive, effectively tracks physical activity in people with Parkinson's Disease and Multiple Sclerosis. This helps doctors make better decisions about patient care. Studies have shown that monitoring exercise and movement can lead to better health outcomes for these conditions. RPM uses technology to track activity levels and encourages more movement, which is important for managing symptoms. While interest in this technology is growing, more evidence is needed to fully understand its impact on health outcomes.12367
Who Is on the Research Team?
Miriam Rafferty, PT, PhD
Principal Investigator
Shirley Ryan AbilityLab
Are You a Good Fit for This Trial?
This trial is for people who can walk on their own or with a cane, have Parkinson's Disease (mild to moderate stages), Parkinsonism, or Multiple Sclerosis. They should be willing to increase physical activity and must agree to the terms of using a remote monitoring app on their smartphone.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Remote Therapeutic Monitoring
Participants receive 1 year of remote therapeutic monitoring via a connected health app and personal activity tracker to monitor their physical activity and exercise behaviors.
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Remote Therapeutic Monitoring Exercise Tracking
Find a Clinic Near You
Who Is Running the Clinical Trial?
Shirley Ryan AbilityLab
Lead Sponsor